GLP-3 / GLP-2 Research Peptide Complex (60 mg)
This two-component research blend contains GLP-3 (20 mg) and a dual GIP/GLP-2 receptor agonist peptide (40 mg), intended for laboratory investigation of metabolic and incretin-related signaling pathways.
The GLP-3 component is studied for activity across glucagon, GIP, and GLP-2 receptor pathways. The dual-receptor component is studied for activity at GIP and GLP-2 receptors.
Research applications include investigations of receptor activity, metabolic signaling, glucose homeostasis, energy balance, and associated cellular responses.
Strictly for laboratory research use only. Not for human or veterinary use.
